BOOST (Bridging Obstacles for Optimal model use via Shared Technical expertise)

Eligibility & scope

Open to researchers at Dutch institutions with an ongoing or recently finished KWF drug research project (start ≥6 months ago, end ≤1.5 years before 1 July 2026). Funds access to clinically relevant preclinical models, technologies and expertise (NAMs, PDOs, GEMMs, orthotopic models, CRO collaborations) to improve translational value. TRL ≥3 required; activities must relate to drug development/optimisation, not fundamental research alone.